Monday, November 16, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each, so you can check any claim. How we source
Press releaseGlobeNewswire· March 24, 2026

SK pharmteco et Prozomix annoncent une collaboration stratégique visant à renforcer leurs capacités en matière de biocatalyse pour la fabrication de médicaments à l’échelle mondiale

View original at globenewswire.com
SK pharmteco et Prozomix annoncent une collaboration stratégique visant à renforcer leurs capacités en matière de biocatalyse pour la fabrication de médicaments à l’échelle mondiale RANCHO CORDOVA, Californie, 24 mars 2026 (GLOBE NEWSWIRE) -- SK pharmteco, une organisation mondiale de premier plan spécialisée dans le d…
Opening lines of the source · GlobeNewswire · short snapshot: read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • As drug molecules become increasingly complex, the use of enzymes offers a greener, more selective, and more cost-effective alternative to traditional chemical synthesis

    60% confidence
  • Prozomix's ability to quickly deliver large quantities of optimized enzymes coupled with SK pharmteco's manufacturing excellence ensures clients can transition from discovery phase to commercial-scale production with unmatched speed and reliability

    60% confidence
  • SK pharmteco's mission is to forge strong relationships with industry leaders based on trust, quality, and a shared commitment to reliably deliver medicines meeting more demanding standards

    60% confidence
  • The partnership with SK pharmteco will fully exploit the potential of Prozomix's enzyme range in the most demanding pharmaceutical applications

    60% confidence
  • Prozomix has earned a global reputation for reducing risks associated with early bioprocess development through its highly diverse enzyme sets and rapid scale-up capabilities

    60% confidence
  • Integration of Prozomix's enzymatic diversity into SK pharmteco's global R&D and manufacturing process complements their current technology platforms and helps offer clients more innovative and sustainable solutions

    60% confidence

Cited in these Via News reports

SK pharmteco et Prozomix annoncent une collaboration stratégique visant à renforcer leurs capacités en matière de biocatalyse pour la fabrication de médicaments à l’échelle mondiale: Source | Via News | finance.via.news